Ethics. Research. Community.

Lung Cancer Drug Opdivo Fails Clinical Trial to Expand Use

New York Times. 
[Record Source: New York Times]
Bristol-Myers Squibb said the drug had not slowed the progression of advanced lung cancer in a test seeking approval to use it as an initial treatment.
Access the full text from your libraries at your institution.  You will be navigating away from EthicShare.

Database Keywords

Detailed Record Information

Record TypeNews/Magazine Article
LicenseNone (All rights reserved) ©